These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 16296290)
1. Pharmacy benefit companies hone strategies to contain costs and improve quality. Edlin M Healthplan; 2001; 42(3):66-8, 70, 72. PubMed ID: 16296290 [No Abstract] [Full Text] [Related]
2. The evolving pharmacy benefit market. Navarro RP Med Interface; 1994 May; 7(5):65-7, 70. PubMed ID: 10134345 [TBL] [Abstract][Full Text] [Related]
3. Economic and clinical impact of innovative pharmacy benefit designs in the management of diabetes pharmacotherapy. Berger J Am J Manag Care; 2007 Apr; 13 Suppl 2():S55-8. PubMed ID: 17417934 [TBL] [Abstract][Full Text] [Related]
4. 4 payer trends to control specialty pharmacy costs. Studin I Manag Care; 2012 May; 21(5):27-9. PubMed ID: 22670484 [No Abstract] [Full Text] [Related]
5. What employers can do about pharmaceutical costs. Norton JA J Health Care Benefits; 1994; 4(1):4-8. PubMed ID: 10137544 [TBL] [Abstract][Full Text] [Related]
6. Pharmacy benefit management: the right Rx? Etheredge L Res Agenda Brief; 1995 Apr; (1):1-11. PubMed ID: 12856664 [No Abstract] [Full Text] [Related]
8. Your next move in managing drug costs. Heenan J Bus Health; 1995 Aug; 13(8):31-2, 36, 38. PubMed ID: 10153416 [TBL] [Abstract][Full Text] [Related]
9. An ounce of prevention: the potential for value-based pharmacy benefits in cost containment. Malley JJ Benefits Q; 2008; 24(4):25-8. PubMed ID: 19048745 [TBL] [Abstract][Full Text] [Related]
10. Pharmacy benefit management companies: redefining their role in health care risk management. Lloyd J Health Care Innov; 1995; 5(5):29-32. PubMed ID: 10160497 [No Abstract] [Full Text] [Related]
11. West Virginia's Rx for drug costs: West Virginia's new prescription drug program is being called "the mouse that roared". Kent C State Legis; 2005 Feb; 32(2):23. PubMed ID: 15704275 [No Abstract] [Full Text] [Related]
12. Control your exposure for costs of injectables, biologics. Capitation Rates Data; 2002 Dec; 7(12):137-8. PubMed ID: 12506731 [No Abstract] [Full Text] [Related]
13. Using clinical evidence to manage pharmacy benefits: experiences of six states. Bergman D; Hoadley J; Kaye N; Crowley J; Hostetter M Issue Brief (Commonw Fund); 2006 Mar; (899):1-14. PubMed ID: 16562357 [TBL] [Abstract][Full Text] [Related]
15. Prescription drug benefit design: the building blocks and their impact on cost. Kopenski F Benefits Q; 2008; 24(4):7-11. PubMed ID: 19048742 [TBL] [Abstract][Full Text] [Related]